Dr. Reddy’s may choose to license toripalimab in New Zealand, Australia, as well...
The pharmaceutical industry continues to be a hotbed of innovation, with activit...
The pharmaceutical industry continues to be a hotbed of innovation, with activit...
The pharmaceutical industry continues to be a hotbed of innovation, with activit...
The pharmaceutical industry continues to be a hotbed of innovation, with activit...
The pharmaceutical industry continues to be a hotbed of innovation, with activit...
The pharmaceutical industry continues to be a hotbed of innovation, with activit...
Tokyo, Japan – Scientists from Tokyo Metropolitan University have proposed a hyp...
“You can't make an asymptomatic person feel better," cardiologist Rita Redberg s...
Using a unique AI tool, built from a half-dozen other algorithms, Every Cure is ...
In the latest edition of STAT's Health Tech newsletter: Vinod Khosla's bold AI p...
The biofilm-forming bacteria E. coli adheres firmly to hydrophobic and hydrophil...
Pfizer and Valneva are delaying the regulatory filing of their Lyme disease vacc...
A study was published in the Proceedings of the National Academy of Sciences exp...
The Phase II clinical trial will assess the efficacy and safety of PBF-999 in re...
Dupixent’s worldwide net sales increased by 37% to $2.49bn Q1 to Q1 2022-23.
